Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Amortizatization of Intangibles (2024 - 2025)

Historic Amortizatization of Intangibles for Century Therapeutics (IPSC) over the last 2 years, with Q3 2025 value amounting to $507000.0.

  • Century Therapeutics' Amortizatization of Intangibles fell 6162.0% to $507000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $4.8 million for FY2024, which is 2078.31% up from last year.
  • Per Century Therapeutics' latest filing, its Amortizatization of Intangibles stood at $507000.0 for Q3 2025, which was down 6162.0% from $647000.0 recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Amortizatization of Intangibles registered a high of $1.3 million during Q2 2024, and its lowest value of $507000.0 during Q3 2025.